| Cynthia A Bradford, MD | |
|
608 Stanton L Young Blvd, Oklahoma City, OK 73104-5014 | |
| (405) 271-6060 | |
| (405) 271-7873 |
| Full Name | Cynthia A Bradford |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 41 Years |
| Location | 608 Stanton L Young Blvd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013998681 | NPI | - | NPPES |
| 100629650C | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 14833 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Mcgee Eye Institute | 3779495353 | 40 |
News Archive
Institutional review boards (IRBs), the committees that oversee protections for human research participants, often come with a higher than expected price tag, according to results of a study published in the April 28 edition of the New England Journal of Medicine.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Point Loma Nazarene University is now accepting applications for its Kyoto Prize Journalism Fellowship, a unique learning opportunity for a journalist who has worked to attain a level of excellence in his or her field and hopes to further integrity in the sciences and arts. The selected journalist will attend the 26th annual Kyoto Prize presentation ceremony and will interact with the latest Kyoto Prize laureates in Kyoto, Japan, November 7-14, 2010.
There are small but robust differences in the effects of different psychotherapies on psychosis symptoms, say the authors of a meta-analysis.
› Verified 3 days ago
| Entity Name | Dean Mcgee Eye Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245209675 PECOS PAC ID: 3779495353 Enrollment ID: O20031103000297 |
News Archive
Institutional review boards (IRBs), the committees that oversee protections for human research participants, often come with a higher than expected price tag, according to results of a study published in the April 28 edition of the New England Journal of Medicine.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Point Loma Nazarene University is now accepting applications for its Kyoto Prize Journalism Fellowship, a unique learning opportunity for a journalist who has worked to attain a level of excellence in his or her field and hopes to further integrity in the sciences and arts. The selected journalist will attend the 26th annual Kyoto Prize presentation ceremony and will interact with the latest Kyoto Prize laureates in Kyoto, Japan, November 7-14, 2010.
There are small but robust differences in the effects of different psychotherapies on psychosis symptoms, say the authors of a meta-analysis.
› Verified 3 days ago
| Entity Name | University Of Oklahoma Heal Sci Ctr College Of Medicine Ophthalmology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477623700 PECOS PAC ID: 2365354511 Enrollment ID: O20031105000246 |
News Archive
Institutional review boards (IRBs), the committees that oversee protections for human research participants, often come with a higher than expected price tag, according to results of a study published in the April 28 edition of the New England Journal of Medicine.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Point Loma Nazarene University is now accepting applications for its Kyoto Prize Journalism Fellowship, a unique learning opportunity for a journalist who has worked to attain a level of excellence in his or her field and hopes to further integrity in the sciences and arts. The selected journalist will attend the 26th annual Kyoto Prize presentation ceremony and will interact with the latest Kyoto Prize laureates in Kyoto, Japan, November 7-14, 2010.
There are small but robust differences in the effects of different psychotherapies on psychosis symptoms, say the authors of a meta-analysis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia A Bradford, MD 608 Stanton L Young Blvd, Oklahoma City, OK 73104-5014 Ph: (405) 271-6060 | Cynthia A Bradford, MD 608 Stanton L Young Blvd, Oklahoma City, OK 73104-5014 Ph: (405) 271-6060 |
News Archive
Institutional review boards (IRBs), the committees that oversee protections for human research participants, often come with a higher than expected price tag, according to results of a study published in the April 28 edition of the New England Journal of Medicine.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Point Loma Nazarene University is now accepting applications for its Kyoto Prize Journalism Fellowship, a unique learning opportunity for a journalist who has worked to attain a level of excellence in his or her field and hopes to further integrity in the sciences and arts. The selected journalist will attend the 26th annual Kyoto Prize presentation ceremony and will interact with the latest Kyoto Prize laureates in Kyoto, Japan, November 7-14, 2010.
There are small but robust differences in the effects of different psychotherapies on psychosis symptoms, say the authors of a meta-analysis.
› Verified 3 days ago
Vinay Ashok Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9821 S May Ave Ste C, Oklahoma City, OK 73159 Phone: 405-691-0505 Fax: 405-691-0507 | |
Jila Noorikolouri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-3013 | |
Dr. Brian Keith Firestone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
David W Parke Ii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1092 | |
Gary Waine Wilson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7101 Nw Expressway, Suite 335, Oklahoma City, OK 73132 Phone: 405-722-2020 Fax: 405-516-6126 | |
David W. Jackson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1095 |